• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌的双突变事件理论

The two-mutational-event theory in medullary thyroid cancer.

作者信息

Jackson C E, Block M A, Greenawald K A, Tashjian A H

出版信息

Am J Hum Genet. 1979 Nov;31(6):704-10.

PMID:517520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1686035/
Abstract

Comparisons are presented of the ages of onset of 20 cases of hereditary medullary carcinoma of the thyroid (MCT) and of 22 sporadic cases of this same type of cancer. These data are compatible with what might be expected by the two-mutational-event theory of the initiation of cancer postulated by Knudson. It had been previously postulated that C-cell hyperplasia of the thyroid was a premalignant change resulting from the first or genetic mutational event in the initiation of this type of cancer. The finding of C-cell hyperplasia in thyroid glands of each of the 10 patients with the hereditary condition and in none of the 10 sporadic patients is compatible with this theory. The C-cell hyperplasia is believed to be the expression of the genetic mutation, which requires a subsequent somatic mutation to transform the initially mutated cell into a cancer cell.

摘要

对20例遗传性甲状腺髓样癌(MCT)和22例散发性同类型癌症的发病年龄进行了比较。这些数据与Knudson提出的癌症起始的双突变事件理论所预期的情况相符。此前曾推测,甲状腺C细胞增生是这种类型癌症起始时第一个或基因性突变事件导致的癌前变化。在10例遗传性疾病患者的甲状腺中均发现了C细胞增生,而10例散发性患者中均未发现,这一发现与该理论相符。C细胞增生被认为是基因突变的表现,需要随后的体细胞突变才能将最初突变的细胞转化为癌细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/5510c2e02a63/ajhg00198-0057-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/f7ca5fd5ca72/ajhg00198-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/62aaeebef1ed/ajhg00198-0056-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/5510c2e02a63/ajhg00198-0057-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/f7ca5fd5ca72/ajhg00198-0056-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/62aaeebef1ed/ajhg00198-0056-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d8/1686035/5510c2e02a63/ajhg00198-0057-a.jpg

相似文献

1
The two-mutational-event theory in medullary thyroid cancer.甲状腺髓样癌的双突变事件理论
Am J Hum Genet. 1979 Nov;31(6):704-10.
2
C-cell hyperplasia preceding medullary thyroid carcinoma.甲状腺髓样癌之前的C细胞增生。
N Engl J Med. 1973 Aug 30;289(9):437-41. doi: 10.1056/NEJM197308302890901.
3
C cell hyperplasia.C细胞增生
Bull Cancer. 1984;71(2):122-4.
4
[Diagnosis and treatment of the precancer state in hereditary medullary thyroid carcinoma].
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-3):1657-61.
5
Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.甲状腺生理性与肿瘤性C细胞增生:不同组织学和生物学实体的区分
Cancer. 1996 Feb 15;77(4):750-6. doi: 10.1002/(sici)1097-0142(19960215)77:4<750::aid-cncr22>3.0.co;2-z.
6
Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study.降钙素和组胺酶在C细胞增生及甲状腺髓样癌中的研究。一项光镜和免疫组化研究。
Am J Pathol. 1978 Jul;92(1):35-52.
7
Recommendations for reporting C cell pathology of the thyroid.甲状腺C细胞病理学报告建议。
Wien Klin Wochenschr. 2002 Apr 15;114(7):274-8.
8
Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications.区分遗传性与散发性甲状腺髓样癌的临床特征。治疗意义。
Arch Surg. 1980 Feb;115(2):142-8. doi: 10.1001/archsurg.1980.01380020012004.
9
Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).甲状腺髓样癌。(6例的临床及内分泌学特征)
Ric Clin Lab. 1981 Apr-Jun;11(2):171-8.
10
Immunohistochemistry of medullary thyroid carcinoma and C-cell hyperplasia by an affinity-purified anti-human calcitonin antiserum.用亲和纯化的抗人降钙素抗血清对甲状腺髓样癌和C细胞增生进行免疫组织化学检测。
Cancer. 1993 Aug 15;72(4):1356-63. doi: 10.1002/1097-0142(19930815)72:4<1356::aid-cncr2820720434>3.0.co;2-0.

引用本文的文献

1
Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.术前识别低危型甲状腺髓样癌:减少甲状腺全切除术的潜在应用。
Sci Rep. 2023 Sep 20;13(1):15663. doi: 10.1038/s41598-023-42907-3.
2
Penile cancer.阴茎癌
Nat Rev Dis Primers. 2021 Feb 11;7(1):11. doi: 10.1038/s41572-021-00246-5.
3
The utility of some modern techniques in understanding thyroid pathology.一些现代技术在理解甲状腺病理学方面的效用。

本文引用的文献

1
Immunoassay of human calcitonin.人降钙素的免疫测定
N Engl J Med. 1970 Oct 22;283(17):890-5. doi: 10.1056/NEJM197010222831702.
2
Mutation and cancer: statistical study of retinoblastoma.突变与癌症:视网膜母细胞瘤的统计学研究
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3. doi: 10.1073/pnas.68.4.820.
3
Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay.通过降钙素测定法早期诊断甲状腺髓样癌。
Endocr Pathol. 1990 Jun;1(2):68-84. doi: 10.1007/BF02915622.
4
Screening for familial medullary thyroid carcinoma: a review.家族性甲状腺髓样癌的筛查:综述
J R Soc Med. 1984 Jul;77(7):585-94. doi: 10.1177/014107688407700712.
5
Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study.人类2A型和2B型多发性内分泌腺瘤中20号染色体缺失:一项双盲研究。
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2525-8. doi: 10.1073/pnas.81.8.2525.
6
Statistical properties of a two-stage model of carcinogenesis.致癌作用两阶段模型的统计学特性。
Environ Health Perspect. 1987 Dec;76:125-31. doi: 10.1289/ehp.8776125.
7
Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.冯·希佩尔-林道病、散发性小脑血管瘤病和肾细胞癌中两阶段突变模型的统计分析。
J Med Genet. 1990 May;27(5):311-4. doi: 10.1136/jmg.27.5.311.
8
Limiting subsequent mutagenic events in carriers of hereditary tumor genes.限制遗传性肿瘤基因携带者后续的致突变事件。
Am J Hum Genet. 1992 Jun;50(6):1350-1.
N Engl J Med. 1971 Nov 11;285(20):1115-20. doi: 10.1056/NEJM197111112852004.
4
Medullary thyroid carcinoma detected by serum calcitonin assay.通过血清降钙素检测发现的甲状腺髓样癌。
Arch Surg. 1972 Apr;104(4):579-86. doi: 10.1001/archsurg.1972.04180040193033.
5
C-cell hyperplasia preceding medullary thyroid carcinoma.甲状腺髓样癌之前的C细胞增生。
N Engl J Med. 1973 Aug 30;289(9):437-41. doi: 10.1056/NEJM197308302890901.
6
Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2.嗜铬细胞瘤、甲状腺髓样癌、甲状旁腺功能亢进症和库欣病家族性研究:2型多发性内分泌腺瘤病
Medicine (Baltimore). 1968 Sep;47(5):371-409. doi: 10.1097/00005792-196809000-00001.
7
Mutation and cancer: neuroblastoma and pheochromocytoma.突变与癌症:神经母细胞瘤和嗜铬细胞瘤
Am J Hum Genet. 1972 Sep;24(5):514-32.
8
Detection of medullary thyroid cancer by calcitonin assay in families.
Ann Intern Med. 1973 Jun;78(6):845-52. doi: 10.7326/0003-4819-78-6-845.
9
Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma.肾上腺髓质增生。家族性甲状腺髓样癌患者的形态计量学分析。
Am J Pathol. 1976 Apr;83(1):177-96.
10
Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report.
Trans Assoc Am Physicians. 1975;88:177-91.